Hypofractionated stereotactic radiotherapy for large arteriovenous malformations

• Published in: Surgical neurology international 2012, Vol.3 (Suppl 2), p.S105-S110
• Main Authors: Wang, Huan-Chih, Chang, Rachel J, Xiao, Furen
• Format: Article
• Language: English
• Subjects: Fractionation; Microsurgery; Mortality; Patients; Radiation therapy; Surgical Neurology International: Stereotactic
• ISSN: 2152-7806; 2229-5097; 2152-7806
• DOI: 10.4103/2152-7806.95421

Cerebral arteriovenous malformations (AVMs) are abnormal connections between the arteries and veins, with possible serious consequences of intracranial hemorrhage. The curative treatment for AVMs includes microsurgery and radiosurgery, sometimes with embolization as an adjunct. However, controversies exist with the treatment options available for large to giant AVMs. Hypofractionated stereotactic radiotherapy (HSRT) is one treatment option for such difficult lesions. We aim to review recent literature, looking at the treatment outcome of HSRT in terms of AVM obliteration rate and complications. The rate of AVM obliteration utilizing HSRT as a primary treatment was comparable with that of stereotactic radiosurgery (SRS). For those not totally obliterated, HSRT makes them smaller and turns some lesions manageable by single-dose SRS or microsurgery. Higher doses per fraction seemed to exhibit better response. However, patients receiving higher total dose may be at risk for higher rates of complications. Fractionated regimens of 7 Gy × 4 and 6-6.5 Gy × 5 may be accepted compromises between obliteration and complication. Embolization may not be beneficial prior to HSRT in terms of obliteration rate or the volume reduction. Future work should aim on a prospectively designed study for larger patient groups and long-term follow-up results.